Skip to main content
Clinical Trials/NCT01499238
NCT01499238
Unknown
Phase 4

Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn

Zekai Tahir Burak Women's Health Research and Education Hospital2 sites in 1 country40 target enrollmentDecember 2011

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Transient Tachypnea of Newborn
Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Enrollment
40
Locations
2
Primary Endpoint
efficacy of nasal SIMV and nasal CPAP in infants with wet lung who are >35 weeks gestational age
Last Updated
14 years ago

Overview

Brief Summary

The investigators aimed to compare the efficacy of nasal SIMV and nasal CPAP in patients with wet lung.

Detailed Description

We aimed to compare two types of ventilatory support in cases of transient tachypnea of newborn who are \>35 gestational week.

Registry
clinicaltrials.gov
Start Date
December 2011
End Date
March 2012
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Responsible Party
Principal Investigator
Principal Investigator

Gamze Demirel

Zekai Tahir Burak Maternity Teaching Hospital

Zekai Tahir Burak Women's Health Research and Education Hospital

Eligibility Criteria

Inclusion Criteria

  • \>35 gestational week

Exclusion Criteria

  • major congenital anomalies

Outcomes

Primary Outcomes

efficacy of nasal SIMV and nasal CPAP in infants with wet lung who are >35 weeks gestational age

Time Frame: 3 months

Secondary Outcomes

  • Complications of respiratory support, respiratory insufficiency(3 months)

Study Sites (2)

Loading locations...

Similar Trials